Chase Investment Counsel’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$441K Hold
2022
Q4
$420K Buy
2022
Q3
$365K Hold
2022
Q2
$362K Hold
2022
Q1
$415K Hold
2021
Q4
$406K Buy
2020
Q3
Sell
2020
Q2
$369K Buy